The award recognises the outstanding value offered by SCTI in its comprehensive international travel insurance policy, TravelCare.
Earlier this year SCTI reduced the minimum number of days its TravelCare policy could be issued for from five days to two, meaning policies now start at just AUD$15.
SCTI says ICT is the owner of a unique process for the preparation, production and freezing of the biological solutions of human stem cells and currently hold 26 patents that have been derived from the intellectual property of its scientists used to develop the stem cell production and cryo-freezing processes.
The agreement grants SCTI global rights to use the IP contained in the patents, the stem cell products and the process itself, to establish clinics for the treatment of patients, set up cryo-storage facilities and the administration of the stem cell products to its customers including clinics, universities, institutes and private research facilities for study and clinical trials.
In the unfortunate event an item is stolen, lost or damaged, SCTI
policies require travellers to have some proof of ownership.
Research undertaken on behalf of SCTI
at the end of 2011 found that those going on a trip of short duration (one to seven days) were more likely not to buy travel insurance.
provides new stem cell solutions, which are being used in the treatment of patients suffering from degenerative disorders of the human body.
For the third year running, SCTI
received a five star rating for "outstanding value" in international travel insurance products by research house CANSTAR CANNEX.
Chairman and CEO, Calvin Cao, says, "We are extremely pleased and excited about the signing of the exclusive License Agreement with ICT.
sells stem cell transplants that it manufactures from rabbit fetuses, with its US-patent pending technology, which has the advantage of eliminating the need for immunosuppression for patient treatment.
is the only company in the world that prepares stem cell transplants of animal fetal origin, of all 200 cell types, for human therapeutic use, and delivers the same worldwide.
At the launch, Murray Johnston, President of the SCTI
, will announce "a unique initiative that spans the smart card industry.